Home › Compare › GPAK vs JNJ

GPAK vs JNJ: Dividend Comparison 2026

GPAK yields 250000.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GPAK wins by $4.567699004441311e+30M in total portfolio value
10 years
GPAK
GPAK
● Live price
250000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.567699004441311e+30M
Annual income
$4,564,107,688,187,857,300,000,000,000,000,000,000.00
Full GPAK calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — GPAK vs JNJ

📍 GPAK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGPAKJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GPAK + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
GPAK pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GPAK
Annual income on $10K today (after 15% tax)
$21,250,000.00/yr
After 10yr DRIP, annual income (after tax)
$3,879,491,534,959,678,500,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, GPAK beats the other by $3,879,491,534,959,678,500,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GPAK + JNJ for your $10,000?

GPAK: 50%JNJ: 50%
100% JNJ50/50100% GPAK
Portfolio after 10yr
$2.2838495022206556e+30M
Annual income
$2,282,053,844,093,928,700,000,000,000,000,000,000.00/yr
Blended yield
99.92%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

GPAK
No analyst data
Altman Z
-8.3
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GPAK buys
0
JNJ buys
0
No recent congressional trades found for GPAK or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGPAKJNJ
Forward yield250000.00% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$4.567699004441311e+30M$20.0K ✓
Annual income after 10y$4,564,107,688,187,857,300,000,000,000,000,000,000.00 ✓$827.78
Total dividends collected$4.567463897060879e+30M$5.6K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GPAK vs JNJ ($10,000, DRIP)

YearGPAK PortfolioGPAK Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$25,010,700$25,000,000.00$10,676$355.77+$25.00M → GPAK
2$58,462,976,402$58,436,214,953.27$11,407$389.39+$58462.96M → GPAK
3$127,722,124,784,416$127,659,569,399,665.92$12,198$426.53+$127722124.77M → GPAK
4$260,784,910,907,288,130$260,648,248,233,768,800.00$13,056$467.62+$260784910907.28M → GPAK
5$497,657,939,618,196,950,000$497,378,899,763,526,240,000.00$13,987$513.12+$497657939618196.94M → GPAK
6$887,590,576,640,622,200,000,000$887,058,082,645,230,600,000,000.00$14,998$563.56+$887590576640622208.00M → GPAK
7$1,479,547,418,610,237,200,000,000,000$1,478,597,696,693,231,600,000,000,000.00$16,098$619.52+$1.4795474186102372e+21M → GPAK
8$2,305,052,548,351,757,200,000,000,000,000$2,303,469,432,613,844,500,000,000,000,000.00$17,295$681.69+$2.3050525483517572e+24M → GPAK
9$3,356,370,330,330,650,300,000,000,000,000,000$3,353,903,924,103,914,000,000,000,000,000,000.00$18,599$750.82+$3.3563703303306504e+27M → GPAK
10$4,567,699,004,441,311,000,000,000,000,000,000,000$4,564,107,688,187,857,300,000,000,000,000,000,000.00$20,022$827.78+$4.567699004441311e+30M → GPAK

GPAK vs JNJ: Complete Analysis 2026

GPAK — Stock

Gamer Pakistan Inc. operates as an e-sports event promotion and product marketing company in Pakistan. It focuses on creating college, inter-university, and professional e-sports events for both men's and women's teams, primarily e-sports opportunities with colleges and universities. The company was incorporated in 2021 and is headquartered in Henderson, Nevada.

Full GPAK Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this GPAK vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GPAK vs SCHDGPAK vs JEPIGPAK vs OGPAK vs KOGPAK vs MAINGPAK vs ABBVGPAK vs MRKGPAK vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.